NEW YORK (GenomeWeb News) - Nanogen today said that Fisher HealthCare will exclusively distribute its MGB Alert real-time PCR products in the US.
 
Fisher HealthCare, a unit of Fisher Scientific International, will have exclusive rights to sell and distribute the products to clinical laboratories. The products will retain the Nanogen MGB Alert brand and Nanogen’s technical support will continue supporting them.
 
Customers will have access to Nanogen products through Fisher in September, said Nanogen.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.